tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Revenue

Compare
104 Followers

Virax Biolabs Group Ltd. Class A Revenue

Virax Biolabs Group Ltd. Class A had a revenue of 4.95K in the quarter ending Sep 30, 2024, with -93.80%. This bring the company's revenue in the last twelve months to 84.87K, Increased -45.74%. In the fiscal year ending Mar 31, 2024, Virax Biolabs Group Ltd. Class A had annual revenue of 156.42K with ― growth.
Revenue (ttm)
84.87K
Revenue Growth
P/S Ratio
Revenue/Employee
$9,201
Employees
17
Market Cap

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2024
156.42K+∞%
Mar 31, 2023
Mar 31, 2022
0.00-123.82K-100.00%
Mar 31, 2021
123.82K23.94K+23.97%
Mar 31, 2020
99.88K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis